Erektin

Erektin original domestic development for the prevention and treatment of multi-pronged comprehensive sexual dysfunction. The main component is an extract Erektina sandy sainfoin. Due to its properties Erektin stimulates the production of endogenous testosterone, governs the complex process of filling the cavernous bodies with blood, improves the elasticity of the vascular wall. It improves sperm production and sperm quality.

Erektin contains energy, mineral components, vitamins and minerals, as well as a special group of substances that perform protective and compensatory function involved in all processes of exchange and are analogues of bioregulators (neurotransmitters and hormones) of the human body. Admission Erektina complex system protects the biosynthesis of sex hormones. It noted a significant optimization of the hormonal balance and metabolism, disturbed under the influence of stress, extreme conditions and chronic diseases. Restored libido. Systematic Erektina intake helps to restore the normal functioning of the reproductive system, improves sperm production and sperm quality.

Erektin used in the prevention and treatment of:

long-term psycho-emotional and physical stress in order to prevent the development of impotence and restore the quality of erections;
reduction of sexual activity on the background of chronic fatigue and fatigue, accompanied by the development of vascular disease, fatigue, immune deficiency and failure in metabolism;
chronic diseases of the genital organs, in which a decrease in androgen production, erectile dysfunction, ejaculation delay and decreased sexual activity.

Manufacturer: Avicena
Composition: dense grass extract sainfoin sandy 0.25g, starch, lactose, MCC, calcium stearate.
Dosing: 1-2 tablets three times a day 30 minutes before meal for 30 days.
Contraindications: individual intolerance, pregnancy, lactation, children under 14 years
Packing: a plastic container 30 tablets of 0.5 g.
Shelf life: 18 months.
Certificate: TU U 15.8-31234777-021: 2005, sanitary-hygienic conclusion from 3.06.2010 №05.03.02-04 \ 37323